Acute Coronary Syndromes (ACS) Dataset

Size: px
Start display at page:

Download "Acute Coronary Syndromes (ACS) Dataset"

Transcription

1 For reference only Do Not Use For more information contact: Acute Coronary Syndromes (ACS) Dataset These are standards current on 10 th May 2007 National Clinical Dataset Development Programme (NCDDP) Support Team Information Services Area 54E Gyle Square 1 South Gyle Crescent Edinburgh EH12 9EB Tel: to: NCDDPsupportteam@isd.csa.scot.nhs.uk Website:

2 PATIENT DETAILS... 4 Patient Identification and Demographics Table... 4 General Practice Details Table... 5 Ambulance Incident Number... 5 ADMISSION DETAILS... 6 Date/ Time of Symptom Onset {ACS}... 6 Date/ Time Call for Help {ACS}... 7 Date/ Time Arrival at Hospital {ACS}... 7 Admitted/ Transfer from location... 8 Patient Admin Status... 8 Initial Diagnosis {ACS}... 8 Method of Admission {ACS}... 9 Admission Ward {ACS} Admitting Consultant Identifier Admitting Consultant Type {ACS} Seen by Cardiologist ADMISSION TREATMENT Where was Aspirin / other Anti platelet Given? Reason Aspirin Not Given Aspirin Contraindications Clopidogrel Reason Clopidogrel Not Given Clopidogrel Contraindications Heparin (Low Molecular Weight Heparin or Intravenous Heparin) Reason Heparin (Low Molecular Weight Heparin or Intravenous Heparin) Not Given Heparin (Low Molecular Weight Heparin or Intravenous Heparin) Contraindications THROMBOLYSIS ECG Determining Reperfusion Treatment Date/ Time of 1st ECG Date/ Time of ECG Determining Reperfusion Treatment Place First ECG Performed Was Reperfusion Attempted Reason Thrombolytic Treatment Not Given Thrombolytic Drug Date/ Time of Reperfusion Treatment Reason if Delay Before Thrombolytic Treatment Where was Initial Reperfusion Treatment Given Bleeding Complications as a Result of Reperfusion Therapy Reperfusion Outcome BLOOD RESULTS Serum Total Cholesterol (Admission) {ACS} Cardiac Enzymes/ Markers Raised Peak Serum Creatinine Kinase Peak Troponin Troponin Assay CHD RISK FACTORS Smoking Status Family History of CHD Acute Coronary Syndromes Dataset 2

3 Previous Myocardial Infarction Previous Angina Hypertension Chronic Kidney Disease Diabetes Management Previous Percutaneous Coronary Intervention (PCI) Previous Coronary Artery Bypass Graft (CABG) INVESTIGATIONS DURING ADMISSION Exercise Tolerance Test Reason for no Exercise Tolerance Test Echocardiography LV Function as Result of Echocardiogram Reason for No Echocardiography Referral for Coronary Angiography Date of Referral for Coronary Angiogram Coronary Angiography During This Admission {ACS} Date of Coronary Angiogram INTERVENTIONS DURING ADMISSION Referral for Revascularisation Date of Referral for Revascularisation Revascularisation {ACS} Date of Revascularization COMPLICATIONS DURING ADMISSION Heart Failure {ACS} Angina {ACS} Reinfarction Cardiac Arrest Date/ Time of 1st Cardiac Arrest Outcome of 1st Cardiac Arrest CARDIAC REHABILITATION Referral to Cardiac Rehabilitation Service Date of Referral to Cardiac Rehabilitation Service Reason for No Referral to Cardiac Rehabilitation DISCHARGE DETAILS Discharge Date {ACS} Discharge Diagnosis {ACS} Discharged on Aspirin / other Antiplatelet Discharged on Warfarin Discharged on Clopidogrel Discharged on Beta Blocker Discharged on Angiotensin Inhibitor Discharged on Statin Discharge Destination {ACS} Discharge / transfer to - location Cause of Death in Hospital {ACS} Person Death Date Episode Sign Off Acute Coronary Syndromes Dataset 3

4 PATIENT DETAILS Patient Identification and Demographics Table Generic Data Items Data Item Definition Format Location Code G This is the reference number of any building 5 characters or set of buildings where events pertinent to NHS Scotland take place. Locations include hospitals, health centres, GP surgeries, clinics, NHS board offices, nursing homes, schools and patient/client s home. Health Record Identifier A Patient Health Record Identifier is a code 14 characters G (set of characters) used to uniquely identify a patient within a health register or a HEALTH RECORDS SYSTEM, e.g. PAS. CHI Number G The Community Health Index (CHI) is a 10 characters population register, which is used in Scotland for health care purposes. The CHI number uniquely identifies a person on the index. Surname G That part of a person's name which is used to describe family, clan, tribal group, or marital association. 35 characters Forename G The forename or given name of a person 35 characters Person Birth Date G The date on which a person was born or is officially deemed to have been born, as recorded on the Birth Certificate. 10 characters (CCYY-MM- DD) Person Current Gender G Ethnic Group (Self Assigned) G Postcode G A statement by the individual about the gender they currently identify themselves to be (i.e. self-assigned). A statement made by the service user about their current ethnic group The code allocated by the Post Office to identify a group of postal delivery points. 1 character Up to 6 characters (2 + 4) 8 characters G The above data items have already been approved and are available in the Health & Social Care Data Dictionary. Acute Coronary Syndromes Dataset 4

5 General Practice Details Table Generic Data Items Data Item Definition Format Registered GP Practice Code G General Medical Practitioners provide general medical services to the population either in partnership with other GMPs or on a single-handed basis. The term GP practice covers both partnerships and singlehanded practices. Each GP practice in Scotland is identified by a unique GP practice code. The practice code is a four-digit code plus a check digit with ranges of codes allocated to each Health Board. 6 characters (right justified) Data Items Data Item Definition Format Ambulance Incident Number A record of the ambulance incident number as per the Scottish Ambulance Service Patient Record Form (PRF). 1 Ambulance Incident Number Definition: A record of the ambulance incident number as per the Scottish Ambulance Service Patient Record Form (PRF). Format: 1 N/A Further Information: The ambulance incident number is comprised of 2 letters - 7 digits - 3 digits. Acute Coronary Syndromes Dataset 5

6 ADMISSION DETAILS Data Items Data Item Definition Format Date/ Time of Symptom Onset {ACS} A record of the time to within 10 minutes, if possible, when 25 characters (CCYY- MM-DDThh:mmTZD) Date/ Time Call for Help {ACS} Date/ Time Arrival at Hospital {ACS} Admitted/ Transfer from location Patient Admin Status Initial Diagnosis {ACS} Method of Admission {ACS} Admission Ward {ACS} Admitting Consultant Identifier Admitting Consultant Type {ACS} Seen by Cardiologist symptoms began. A record of the time of the initial call by patient, relative or attendant. Date/time patient first arrives at hospital. The type of location from which a patient is admitted or transferred for care. A record of the patients administration status A record of a working diagnosis at the time of admission. A record of the process by which the patient was admitted to hospital. Refers to the unit to which the patient is admitted either from A&E or directly by ambulance service and where patient will spend majority of first 24 hours in hospital. A record of the unique identifier for the clinician having primary rather than advisory care of the patient immediately (first 24 hours) after admission to hospital A record of the clinician having primary rather than advisory care of the patient immediately (first 24 hours) after admission to hospital A record of whether the patient is seen by a cardiologist or other physician with a specialist interest in cardiology, at any time during this admission. 25 characters (CCYY- MM-DDThh:mmTZD) 25 characters (CCYY- MM-DDThh:mmTZD) ISD reference file 7 characters Date/ Time of Symptom Onset {ACS} Definition: A record of the time to within 10 minutes, if possible, when symptoms began. Format: 25 characters (CCYY-MM-DDThh:mmTZD) Acute Coronary Syndromes Dataset 6

7 N/A Sub-data item: Verification Level Code Value Level 0 Actual Level 1 Estimated Level 2 Date not required Level 3 Not known Further information: Where there is a prodrome of intermittent pain the time recorded should be the time of onset of those symptoms which led the patient to call for help. Routine ambulance data should be used to provide symptom onset information. Where admission followed an out of hospital cardiac arrest with no better information available use the time if arrest for onset of symptoms. Recording Guidance: Valid date >1/1/2000 and <= today. Use 24 hour clock Date/ Time Call for Help {ACS} Definition: A record of the time of the initial call by patient, relative or attendant. Format: 25 characters (CCYY-MM-DDThh:mmTZD) N/A Sub-data item: Verification Level Code Value Level 0 Actual Level 1 Estimated Level 2 Date not required Level 3 Not known Further information: This may be to a GP, NHS 24, or the ambulance service. This time may be available from the ambulance service record as the time of the emergency call but may only be correct when a 999 call is made to the Ambulance service. Make sure you know to whom the initial call was made. If the call was to a GP (or deputising service), or NHS 24 you will have to establish this time as accurately as possible from the patient. The call time should be taken from the ambulance patient report form (PRF) and is when the caller's telephone number, exact location of the incident and nature of chief complaint are known. Recording Guidance: Valid date >1/1/2000 and <= today. Use 24 hour clock Date/ Time Arrival at Hospital {ACS} Definition: A record of the date/time patient first arrives at hospital Format: 25 characters (CCYY-MM-DDThh:mmTZD) N/A Acute Coronary Syndromes Dataset 7

8 Sub-data item: Verification Level Code Value Level 0 Actual Level 1 Estimated Level 2 Date not required Level 3 Not known Further information: Either A&E, CCU, MAU, or assessment unit. Routine ambulance data. It is recommended that this be used by all as the time of arrival rather than time of registration or time of first ECG. Use A&E registration time if self presented or time of ambulance arrival at hospital if direct admission. Recording Guidance: Valid date >1/1/2000 and <= today. Use 24 hour clock Admitted/ Transfer from location Definition: The type of location from which a patient is admitted or transferred for care. Format: 25 characters (CCYY-MM-DDThh:mmTZD) N/A Further information: ISD Reference File. This is only relevant for those patients who are admitted/transferred directly from another NHS Location for revascularisation or inpatient angiography with a view to revascularisation. This is not relevant for those patients admitted from home. This is the location of where a patient has been admitted or transferred from. A location is any building or set of buildings where events pertinent to the NHSSCOTLAND take place. Locations include hospitals, health centres, GP surgeries, clinics, NHS board offices, nursing homes, schools and patients/clients home. Patient Admin Status Definition: A record of the patient s administration status 01 NHS 02 Private 03 Amenity NHS patient but procedure carried out in private hospital. 04 Visitor Any patient that does not live in the local catchment area, includes holiday makers and overseas tourists Initial Diagnosis {ACS} Definition: A record of a working diagnosis at the time of admission. Acute Coronary Syndromes Dataset 8

9 01 Definite myocardial infarction Diagnosis based on unequivocal changes of infarction on admission ECG (ST elevation) 02 Probable myocardial infarction 03 Acute coronary syndrome 04 Chest pain of uncertain cause and appropriate history. Should be used where there is strong likelihood of infarction on history and an abnormal ECG without ST elevation or LBBB. This is a working diagnosis needing confirmation by further ECGs and/or biochemical markers. See 'Reason if delay before thrombolytic treatment for advice on what to enter when first ECGs are not diagnostic and a subsequent ECG is diagnostic and results in reperfusion treatment being given. Includes appearance at admission of non Q wave (subendocardial) infarction. Covers all other suspected acute coronary syndromes where confirmation of diagnosis subject to troponin results Single episode of cardiac sounding chest pain with admission thought appropriate to exclude ischaemic event. 05 Other initial diagnosis Other (usually non-cardiac) diagnosis such as acute aortic dissection, pancreatitis, etc subsequently found to be an infarction. Also to be used where patient is already in hospital. Further information: The primary purpose is to identify those patients who are admitted with a diagnosis of definite MI (ST elevation MI). Do not change initial diagnosis on the basis of further ECGs or enzymes/markers. Note: This standard will be updated when a new definition of Acute Coronary Syndrome is available. Method of Admission {ACS} Definition: A record of the process by which the patient was admitted to hospital. 01 Called GP who saw patient before calling emergency services 02 Called GP who called emergency service before seeing patient Use also when patient sees GP at surgery, drop in night time clinic etc. In some instances the GP may not actually see the patient. Acute Coronary Syndromes Dataset 9

10 03 Called GP, told to make own way to hospital 04 Called Made own way to hospital (did not call anyone) 06 Patient admitted from outpatient setting This includes Rapid Access Chest Pain Clinics 07 Patient already in hospital If the patient is already in hospital with another diagnosis it is only necessary to enter the date of symptom onset and the date of arrival at hospital. 08 Transferred in for PCI/Surgery Use when admitted by transfer from another hospital for consideration of primary or rescue angioplasty or surgical procedure. 09 Transferred in for primary treatment Use this option for transfer from any other hospital for primary treatment (e.g. thrombolysis) or where split management of acute coronary events takes place. If transfer is for primary or rescue angioplasty use option Other Includes other routes of entry to hospital (became ill visiting hospital etc) Further Information: In every case the caller refers to the patient or other nonprofessional in attendance. Admission Ward {ACS} Definition: A record of the unit to which the patient is admitted either from A&E or directly by ambulance service and where patient will spend majority of first 24 hours in hospital. 01 Coronary care unit A unit specified for this purpose including those with shared facilities with ITU, or HDU, or a dedicated CCU which is part of a general medical ward or a dedicated cardiac ward and where the major part of early management takes place. 02 Acute admissions unit A unit for the assessment of non-specific acute medical admissions. 03 General medical ward Where this is separate from a CCU. 04 Intensive therapy unit Where this is separate from a CCU, and is not the usual place of care for early infarction (post-arrest or when CCU is full, etc). 05 Cardiac ward (non A cardiac ward without a specific CCU function CCU) 06 Stepdown ward A facility normally used primarily for patients after initial care on CCU Acute Coronary Syndromes Dataset 10

11 07 Died in A&E Very important for interpretation of mortality data. 98 Other To record patients admitted to non-medical wards or who had infarction while already in hospital. Further Information: If patient admitted direct to Catheter Lab, enter facility to which patient admitted on leaving lab. Admitting Consultant Identifier Definition: A record of the unique identifier for the clinician having primary rather than advisory care of the patient immediately (first 24 hours) after admission to hospital Format: 7 characters N/A Further Information: This is not the A&E consultant. The admitting consultant identifier has the same format as the General Medical Council number. Admitting Consultant Type {ACS} Definition: A record of the clinician having primary rather than advisory care of the patient immediately (first 24 hours) after admission to hospital 01 Cardiologist Cardiologist or physician with a major interest in cardiology. 02 Other general physician All other physicians. 98 Other Patient admitted under another discipline, e.g. surgeon. Further Information: This is not the A&E consultant Seen by Cardiologist Definition: A record of whether the patient is seen by a cardiologist or other physician with a specialist interest in cardiology, at any time during this admission. Code Value 00 No 01 Yes Acute Coronary Syndromes Dataset 11

12 02 Discussed with cardiologist but not seen Further Information: Patients may be admitted by a general physician then later seen by a cardiologist. Acute Coronary Syndromes Dataset 12

13 ADMISSION TREATMENT Data Items Data Item Definition Format Where was Aspirin / other Anti platelet Given? A record of if and when aspirin or other anti platelet drug was first given to patient. Reason Aspirin Not Given Aspirin Contraindications Clopidogrel Reason Clopidogrel Not Given Clopidogrel Contraindications Heparin (Low Molecular Weight Heparin or Intravenous Heparin) Reason Heparin (Low Molecular Weight Heparin or Intravenous Heparin) Not Given Heparin (Low Molecular Weight Heparin or Intravenous Heparin) Contraindications A record of the reason aspirin/other anti-platelet was not given. A record of the reason aspirin/other anti-platelet is contraindicated. A record of whether Clopidogrel was given on admission. A record of the reason Clopidogrel was not given on admission. A record of the reason why Clopidogrel is contraindicated. A record of whether Heparin (Low Molecular Weight Heparin or Intravenous Heparin) was given on admission. A record of the reason Heparin (Low Molecular Weight Heparin or Intravenous Heparin) was not given. A record of the reason why Heparin (Low Molecular Weight Heparin or Intravenous Heparin) is contraindicated. Where was Aspirin / other Anti platelet Given? Definition: A record of if and when aspirin or other antiplatelet drug was first given to patient. 00 Not given 01 Already on aspirin / antiplatelet drug 02 Aspirin / antiplatelet drug given out of hospital Regular use of aspirin / antiplatelet before this episode. Ignore the administration of additional doses by paramedics. Aspirin or other anti platelet drug started for this episode before admission. Acute Coronary Syndromes Dataset 13

14 03 Aspirin / antiplatelet drug given after arrival in hospital Patient not previously taking any antiplatelet drug. Reason Aspirin Not Given Definition: A record of the reason aspirin/other anti-platelet was not given. 00 None No reason given 01 Contraindicated Clinical reason aspirin/other anti-platelet should not be given 02 Adverse Reaction Patient experienced unwanted effects/allergic to aspirin/other anti-platelet 03 Not tolerated Patient cannot tolerate aspirin/other antiplatelet 04 Not indicated e.g. person may already be on a similar medication 05 Patient declined Patient chose not to be prescribed aspirin/other antiplatelet 98 Other Aspirin Contraindications Definition: A record of the reason aspirin/other anti-platelet is contraindicated. Code Value 01 Allergic 02 GI Bleed 03 Dyspepsia 04 Severe liver abnormalities 05 Intolerant 06 Cerebral haemorrhage 07 Haemoptysis 08 Pregnant Further Information: Contra-indication in pregnancy should be supported by clinical data (teratogenicity or foetotoxicity) or by strong pre-clinical data such as teratogenicity, mutagenicity and carcinogenicity at low doses. (European Medicines Agency Evaluation of Medicines for Human Use - Doc. Ref.: EMEA/CHMP/64302/2005 (CHMP)) Acute Coronary Syndromes Dataset 14

15 Clopidogrel Definition: A record of whether Clopidogrel was given on admission. Code Value 00 No 01 Yes Further Information: This is relevant for only those patients who are deemed as Acute Coronary Syndrome patients on admission. Reason Clopidogrel Not Given Definition: A record of the reason Clopidogrel was not given on admission. 00 None No reason given 01 Contraindicated Clinical reason Clopidogrel should not be given 02 Adverse Reaction Patient experienced unwanted effects/allergic to Clopidogrel 03 Not tolerated Patient cannot tolerate Clopidogrel 04 Not indicated Patient may already be on a similar medication 05 Patient declined Patient chose not to be prescribed Clopidogrel 98 Other Further information: Where clinical guidelines recommend the prescription of a specific drug or class of drug for a particular condition, this data item allows the recording of the reason why that guidance was not followed. It is intended to support the clinical governance agenda Clopidogrel Contraindications Definition: A record of the reason why Clopidogrel is contraindicated. 00 None None 01 Specific clinical diagnosis 02 Co-morbidities This includes concomitant diseases 03 Demographic factors e.g. gender, age Acute Coronary Syndromes Dataset 15

16 04 Predispositions This includes metabolic or immunological factors and prior adverse reactions 05 Pregnancy 06 Lactation 07 Strong theoretical reasons e.g. on grounds of pharmacokinetics, pharmacodynamics, or common state of knowledge in medicine Heparin (Low Molecular Weight Heparin or Intravenous Heparin) Definition: A record of whether Heparin (Low Molecular Weight Heparin or Intravenous Heparin) was given on admission. Code Value 00 No 01 Yes Further Information: This is relevant for only those patients who are deemed as Acute Coronary Syndrome patients on admission. Reason Heparin (Low Molecular Weight Heparin or Intravenous Heparin) Not Given Definition: A record of the reason Heparin (Low Molecular Weight Heparin or Intravenous Heparin) was not given. 00 None No reason given 01 Contraindicated Clinical reason Heparin should not be given 02 Adverse Reaction Patient experienced unwanted effects/allergic to Heparin 03 Not tolerated Patient cannot tolerate Heparin 04 Not indicated Patient may already be on a similar medication 05 Patient declined Patient chose not to be prescribed Heparin 98 Other Acute Coronary Syndromes Dataset 16

17 Heparin (Low Molecular Weight Heparin or Intravenous Heparin) Contraindications Definition: A record of the reason why Heparin (Low Molecular Weight Heparin or Intravenous Heparin) is contraindicated. 00 None None 01 Specific clinical diagnosis 02 Co-morbidities This includes concomitant diseases 03 Demographic factors e.g. gender, age 04 Predispositions This includes metabolic or immunological factors and prior adverse reactions 05 Pregnancy 06 Lactation 07 Strong theoretical reasons e.g. on grounds of pharmacokinetics, pharmacodynamics, or common state of knowledge in medicine Acute Coronary Syndromes Dataset 17

18 THROMBOLYSIS Data Items Data Item Definition Format ECG Determining Reperfusion Treatment A record of the ECG appearances upon which a decision to offer reperfusion treatment including angioplasty, Date/ Time of 1st ECG Date/ Time of ECG Determining Reperfusion Treatment Place First ECG Performed Was Reperfusion Attempted Reason Thrombolytic Treatment Not Given Thrombolytic Drug Date/ Time of Reperfusion Treatment Reason if Delay Before Thrombolytic Treatment Where was Initial Reperfusion Treatment Given Bleeding Complications as a Result of Reperfusion Therapy Reperfusion Outcome was based. A record of the date and time of the first ECG recorded after the start of symptoms. A record of the date and time the ECG that determined the reperfusion treatment, was taken. A record of where the first ECG was performed. A record of whether or not reperfusion was attempted on this patient. A record of the explanation of why thrombolysis was not performed where it might be expected to be performed. A record of the agent for first thrombolytic treatment. A record of the date and time of start of reperfusion treatment whether by bolus or infusion. A record of the reason for delay, if any, before thrombolytic treatment is given. A record of where the initial reperfusion treatment was given A record of bleeding complications due to reperfusion therapy A record of the result of primary thrombolytic treatment prior to any further reperfusion treatment 25 characters (CCYY- MM-DDThh:mmTZD) 25 characters (CCYY- MM-DDThh:mmTZD) 25 characters (CCYY- MM-DDThh:mmTZD) ECG Determining Reperfusion Treatment Definition: A record of the ECG appearances upon which a decision to offer reperfusion treatment including angioplasty, was based. Acute Coronary Syndromes Dataset 18

19 01 ST segment elevation Appearances considered typical of acute myocardial infarction. 02 Left bundle branch block New LBBB. Whether or not LBBB is 'new' causes practical difficulties. In order to confirm this it is necessary to have evidence that it did not exist before this event, by comparing with previous ECGs. It follows that unless there is definite ST segment elevation in addition to LBBB, the admission diagnosis for a patient with LBBB of uncertain duration has to be 'Probable MI'. Can be used to calculate TIMI risk score for Acute MI. 03 ST segment depression Any degree of ST segment depression involving more than one lead without any ST elevation (except a VR). 04 T wave changes only Includes non Q wave infarction. 05 Other abnormality All other abnormalities thought potentially relevant to this admission e.g. arrhythmias, conduction disturbances. 06 Normal ECG Further information: This can include any 12 lead ECG performed in the pre hospital setting. If ST Elevation consistent with infarction is recorded on any ECG during the episode, regardless of treatment, the final diagnosis should be Myocardial Infarction (ST Elevation). Date/ Time of 1st ECG Definition: A record of the date and time of the first ECG recorded after the start of symptoms Format: 25 characters (CCYY-MM-DDThh:mmTZD) N/A Sub data item: Verification Level Code Value Level 0 Actual Level 1 Estimated Level 2 Not known Recording Guidance: Valid date >1/1/2000 and <= today. Use 24 hour clock Date/ Time of ECG Determining Reperfusion Treatment Definition: A record of the date and time the ECG that determined the reperfusion treatment, was taken Format: 25 characters (CCYY-MM-DDThh:mmTZD) Acute Coronary Syndromes Dataset 19

20 N/A Sub data item: Verification Level Code Value Level 0 Actual Level 1 Estimated Level 2 Not known Recording Guidance: Valid date >1/1/2000 and <= today. Use 24 hour clock Place First ECG Performed Definition: A record of where the first ECG was performed. 01 Ambulance An ECG performed in any location by ambulance paramedic staff as a result of an emergency call 02 In hospital In this hospital 98 Other healthcare facility Includes general practice or care home where the ECG was performed by a non paramedic Further Information: This refers to the first ECG recorded, not necessarily the diagnostic ECG. Was Reperfusion Attempted Definition: A record of whether or not reperfusion was attempted on this patient. 00 No 01 Thrombolytic drug Includes one or more doses of any thrombolytic agent, although only timing of the first dose to be recorded. Use even if there was reason for delay before treatment. 02 Primary PCI Either as an elective decision or because thrombolytic treatment contraindicated. 03 Facilitated PCI PCI performed in the acute setting as soon as possible after thrombolysis for acute STEMI (or new LBBB) with a clear history of MI, provided as a routine treatment in addition to thrombolysis. Where, as a part of an agreed protocol, thrombolysis is given before a PCI is Acute Coronary Syndromes Dataset 20

21 performed. Further information: This data item only refers to the initial reperfusion strategy. Reperfusion therapy implies either lytic therapy (thrombolytic drug) or mechanical treatment (PCI) or both. Reason Thrombolytic Treatment Not Given Definition: A record of the explanation of why thrombolysis was not performed where it might be expected to be performed. 00 No reasons No reason why thrombolysis not performed. This should include any administration failures 01 Contraindicated Generally acknowledged clinical contraindication to performing thrombolysis exists. This should include too late, risk of haemorrhage, uncontrolled hypertension, previous stroke, recent surgery etc 02 Not indicated No clinical indication for thrombolysis 03 Clinical Decision Clinical judgement of inappropriateness of thrombolysis in an individual patient due to their specific set of circumstances 04 Not available Thrombolysis not available 05 Not applicable 06 Patient declined Patient chose not to have thrombolysis 07 Diagnostic uncertainty 08 Primary PCI 98 Other Further Information: Thrombolytic therapy may be expected when clinical guidelines recommend thrombolysis should be performed. Thrombolytic Drug Definition: A record of the agent given for thrombolytic treatment. Format: Characters Field length: 2 Code Value 01 Alteplase 02 Reteplase 03 Streptokinase 04 Tenecteplase Acute Coronary Syndromes Dataset 21

22 05 Urokinase 98 Other Related data items: Thrombolysis Status, Date / Time of Reperfusion Treatment, Reason for no Thrombolysis {CHD} Date/ Time of Reperfusion Treatment Definition: A record of the date and start time of reperfusion treatment whether by bolus or infusion. Format: 25 characters (CCYY-MM-DDThh:mmTZD) N/A Sub data item: Verification Level Code Value Level 0 Actual Level 1 Estimated Level 2 Not known Further information: Required for calculation of time of arrival to time of thrombolysis. Required for time from onset symptoms to time of thrombolysis. Required for time from onset symptoms to time of thrombolysis. Recording Guidance: Valid date >1/1/2000 and <= today. Use 24 hour clock Reason if Delay Before Thrombolytic Treatment Definition: A record of the reason for delay, if any, before thrombolytic treatment is given. 00 No delay This means that there was no operational delay regardless of the time to treatment. 01 Sustained hypertension As defined by local protocol. 02 Clinical concern about recent cerebrovascular event or surgery If delay results from need to check on significance of recent cerebrovascular event or operative procedure. 03 Delay obtaining consent If patient requests delay - use only when the patient wishes to take time to consider use of a conventional (non trial) thrombolytic drug. Other delays obtaining consent, or arranging randomisation for a therapeutic study should be recorded under 98 Other. Acute Coronary Syndromes Dataset 22

23 04 Cardiac arrest Cardiac arrest includes an arrest occurring before arrival in hospital. 05 Obtaining consent for a therapeutic trial Consent for a therapeutic trial. Use only for an approved study 06 Hospital Administrative Failure Includes any valid procedural reason why thrombolytic treatment was delayed in hospital 07 Ambulance procedural delay 08 Ambulance 12 lead ECG not diagnostic of STEMI 09 Consideration for primary PCI 10 No identifiable reason for delay 98 Other including portering delay. This includes e.g. incorrect address or difficulty finding address, unable to gain entry to patient s house, patient reasons e.g. initial refusal to go to hospital or extended domestic arrangements, or adverse weather conditions. When initial ambulance ECG is not diagnostic of STEMI. Where consideration for primary PCI led to a delay in providing thrombolysis. On review of clinical case no valid reason for delay is obvious (retrospective data entry) Further Information: NHSQIS require 50% of patients to receive thrombolysis within 30 minutes of admission Where was Initial Reperfusion Treatment Given Definition: A record of where the initial reperfusion treatment was given. 01 Ambulance This includes the patient's home. 02 GP / Out of Hours 03 Community hospital 04 In A&E Regardless of who initiated treatment there. 05 In CCU (direct admission) A patient who enters CCU directly from an ambulance without assessment by hospital clinical staff before arrival. 06 In CCU (slowtrack) Implies admission via A&E or other assessment unit where a diagnosis of definite infarction was made, followed by transfer to CCU where thrombolytic treatment was initiated. 07 Elsewhere in hospital Includes acute admission units, general medical wards and catheter laboratories. Bleeding Complications as a Result of Reperfusion Therapy Definition: A record of bleeding complications due to reperfusion therapy. Acute Coronary Syndromes Dataset 23

24 Code Value 00 None 01 Intracranial bleed 02 Retroperitoneal bleed 03 Any other spontaneous bleed with Hb fall >= 5g or Hct > 15% 04 Bleed from any non-intracranial or non-retroperitoneal site with Hb fall > 3g and < 5 g 05 Bleed from any non-intracranial or non-retroperitoneal site with Hb fall <=3 g Further Information: This can be used for both thrombolytic treatment and any bleed post PCI. Options are listed in order of precedence: use the highest item that applies. Use if any antiplatelet/ anticoagulant/ fibrinolytic drug is thought to be responsible for bleeding. Reperfusion Outcome Definition: A record of the result of primary thrombolytic treatment prior to any further reperfusion treatment 01 Successful Reduction in ST Segment elevation by >50% within 90 minutes 02 Unsuccessful Persistent ST Segment elevation despite thrombolysis after 90 minutes 03 Not applicable Record if thrombolytic treatment is not administered Further Information: An example of primary thrombolytic therapy is an additional dose of thromboytic drug. Acute Coronary Syndromes Dataset 24

25 BLOOD RESULTS Data Items Data Item Definition Format Serum Total Cholesterol (Admission) {ACS} A record of a fasting sample serum total cholesterol level taken within 24 hours of nn.nn (mmol/l) Cardiac Enzymes/ Markers Raised Peak Serum Creatinine Kinase Peak Serum Troponin Troponin Assay admission A record of whether or not the patient has raised cardiac enzymes / markers The highest serum creatinine kinase level in a series of measurements. The highest serum troponin level in a series of measurements, during this admission. A record of the specific type of troponin assay used nnn (units) nnn.nn (units) Serum Total Cholesterol (Admission) {ACS} Definition: A record of a fasting sample serum total cholesterol level taken within 24 hours of admission Format: nn.nn (mmol/l) N/A Further Information: Cholesterol levels change within 24 hrs of an MI and do not return to normal levels for up to 3 months Cardiac Enzymes/ Markers Raised Definition: A record of whether or not the patient has raised cardiac enzymes / markers 00 No Enzyme activity (CK, CKMB or other cardiac enzyme) on a single sample NOT greater than twice the upper limit of normal for the hospital laboratory. For other markers e.g. troponin, use local normal range for infarction. 01 Yes Enzyme activity (CK, CKMB or other cardiac enzyme) on a single sample greater than twice Acute Coronary Syndromes Dataset 25

26 the upper limit of normal for the hospital laboratory. For other markers e.g. troponin, use local normal range. 02 Test not done 98 Test done but results not available If the patient dies before bloods are taken enter 'Not known'. Peak Serum Creatinine Kinase Definition: The highest serum creatinine kinase level in a series of measurements. Format: nnn (units) N/A Further information: The biochemical definition of acute infarction and acute coronary syndromes has to take account of proposed changes of biochemical criteria which have not yet gained widespread agreement or acceptance. Entry of the peak value for the two markers allows either or both to be recorded. This allows for the reality that some Trusts are using different cut off points for troponin for the definition of infarction. The rest are likely still to be using creatine kinase (CK). Where serial CK levels are measured, the peak (highest) value should be recorded, but in situations where a single CK level is measured, this should be used. Peak Troponin Definition: The highest serum troponin level in a series of measurements. Format: nnn.nn (units) N/A Further information: These values are presently collected for future analysis when standardisation of troponin assay is feasible. Where serial troponin levels are measured, the peak (highest) value should be recorded, but in situations where a single troponin level is measured, this should be used. This data item should record the highest level during this admission. Troponin Assay Definition: A record of the specific type of troponin assay used. 01 Troponin I 02 Troponin T Acute Coronary Syndromes Dataset 26

27 Further information: It is important to know which assay type is used to measure troponin since different assays will have different reference ranges. Acute Coronary Syndromes Dataset 27

28 CHD RISK FACTORS Data Items Data Item Definition Format Smoking Status A record of tobacco consumption at date of contact. Family History of CHD A record of family history of premature CHD by diagnosis. Previous Myocardial A record of whether or not an Infarction individual has had a confirmed diagnosis of MI in the past confirmed by abnormal ECG findings e.g. Q-wave (and/or ETT and angiography results). Option for >1 with attached dates. Previous Angina A record of whether the patient has previously been diagnosed with angina. Hypertension A record of whether or not an individual is already receiving treatment (drug, dietary, or lifestyle) for hypertension, or has a record of BP > 140/90 Chronic Kidney Disease A record of whether or not the individual has chronic kidney disease. Diabetes Management The type(s) of management of a Previous Percutaneous Coronary Intervention (PCI) Previous Coronary Artery Bypass Graft (CABG) patient s diabetes. A record of whether or not reperfusion of coronary arterial blood-flow by PTCA was performed prior to this admission. A record of whether or not reperfusion of coronary arterial blood-flow by CABG was performed at any time prior to this admission. Smoking Status Definition: A record of tobacco consumption at date of contact. Acute Coronary Syndromes Dataset 28

29 10 Never smoked May have tried smoking once or twice 11 Ex smoker Has not smoked for at least 12 months 12 Current non-smoker Has stopped smoking within the past 12 months 13 Current smoker 97 Patient declined Patient chose not to disclose this information Further Information: Includes all types of tobacco consumption. Family History of CHD Definition: A record of family history of premature CHD by diagnosis. 00 No 01 Yes Further Information: A family history of CHD is pertinent in father or brother before 55 and mother or sister before 65. Previous Myocardial Infarction Common name: Previous MI, personal history of MI Definition: Record of whether or not an individual has had a confirmed diagnosis of MI in the past proven by ECG, cardiac enzymes or heart perfusion scan or other reliable methodology, but not on clinical features alone. 00 No 01 Yes Further information: Confirmed by history and/ or abnormal investigative findings e.g. Q-wave on ECG (and/or ETT and angiography results) indicative of STEMI. Recording guidance: Systems must allow for recording of multiple previous MI s, with associated dates. Previous Angina Acute Coronary Syndromes Dataset 29

30 Definition: A record of whether the patient has previously been diagnosed with angina. 00 No 01 Yes Further Information: Symptoms thought to be indicative of ischaemic cardiac pain either at rest or on exertion existing at least two weeks prior to this admission. Symptoms indicative of ischaemic heart disease include chest pain of cardiac nature at rest or on exertion which may be relieved by rest and/or medical therapy e.g. administration of nitrates. Note: This standard will be updated when a new definition of Acute Coronary Syndrome is available Hypertension Common name: HBP Definition: A record of whether or not an individual is already receiving treatment (drug, dietary, or lifestyle) for hypertension, or has a record of BP > 140/90 00 No 01 Yes Further information: The patient must have a BP >140/90 on two occasions prior to admission. Note: The definition of 'hypertension' is subject to periodic revision. The prevailing definition at the time of data recording should be used. This definition complies with current WHO-ISH and SIGN guidelines and will be updated to comply with new SIGN guidelines when they are available. Chronic Kidney Disease Common name: CKD Main source of standard: US National Kidney Foundation Definition: Record of whether or not the individual has chronic kidney disease. Acute Coronary Syndromes Dataset 30

31 00 No 01 Yes Further information: CKD is defined as either kidney damage or Glomerular Filtration Rate (GFR) <60mL/min/1.73m 2 for 3 months, where kidney damage is defined as pathologic abnormalities or markers of damage, including abnormalities in blood or urine tests or imaging studies. This is the US National Kidney Foundation definition for Chronic Kidney Disease as published in Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification which can be found at: US National Kidney Foundation - K/DOQI guidelineshttp:// This definition will almost certainly be adopted by renal services and registries in both Scotland and England. The formula for calculation of estimated GFR is: e GFR = x SCr x age x (if female) x (if black) e GFR is reported in ml/min/1.73 m 2 SCr: serum creatinine in mg/dl (divide by 88.4 to convert from mol/l) CKD Stage Description egfr (ml/min/1.73m 2 ) 1 Kidney damage + normal or GFR >90 2 Kidney damage + mild GFR Moderate GFR Severe GFR Kidney failure <15 (or dialysis) Diabetes Management Definition: The type(s) of management of a patient s diabetes 00 None 01 Dietary Control 02 Oral Hypoglycaemic 03 Insulin 04 Not yet established Newly diagnosed diabetes for which definitive management has not yet been established Acute Coronary Syndromes Dataset 31

32 Previous Percutaneous Coronary Intervention (PCI) Definition: A record of whether or not reperfusion of coronary arterial blood-flow by PTCA was performed prior to this admission. 00 No 01 Yes Previous Coronary Artery Bypass Graft (CABG) Definition: A record of whether or not reperfusion of coronary arterial blood-flow by CABG was performed at any time prior to this admission. 00 No 01 Yes Acute Coronary Syndromes Dataset 32

33 INVESTIGATIONS DURING ADMISSION Data Items Data Item Definition Format Exercise tolerance test A record of whether or not an individual has undergone an exercise tolerance test. Reason for no Exercise An explanation of why an tolerance test exercise tolerance test was not performed where it might be expected to be performed, e.g. when clinical guidelines recommend echo should be performed Echocardiography A record of whether or not echocardiographic investigation has been performed LV function as result of echocardiogram Reason for not performing echocardiogram Referral for coronary angiography Date of referral for coronary angiogram Coronary angiography during this admission {ACS} Date of coronary angiogram A high level report on the findings of an echocardiography investigation, with reference to abnormalities which may be related to ischaemic heart disease and/or valvular disease. An explanation of why no echocardiogram was performed where it might be expected to be performed, e.g. when clinical guidelines recommend echo should be performed A record of referral for coronary angiography in another hospital A record of the date a patient was referred for coronary angiogram A record of whether or not coronary angiography investigation has been performed for delineation of coronary arterial blood-flow during this admission A record of the date when a coronary angiogram was performed. 10 characters (CCYY- MM-DD) 10 characters (CCYY- MM-DD) Exercise Tolerance Test Common name: ETT, Exercise ECG Definition: A record of whether or not an individual has undergone an exercise tolerance test. Acute Coronary Syndromes Dataset 33

34 Code Value Explanatory Notes 00 No ETT not performed 01 Yes 02 Planned Includes requested and referred for 99 Unknown Related data items: Reason for no Exercise Tolerance Test Further information: For various clinical conditions, specific clinical guidelines recommended ETT investigation. Whether or not an ETT was performed in line with such guidelines may be needed to assess the quality of clinical care, as in the GMS Quality Outcomes Framework. Exercise tolerance testing (ETT) has been shown to be of value in assessing prognosis of patients with coronary artery disease. An ETT is also helpful in patients at high risk of CHD, where a positive test can provide useful prognostic information. (Ref. SIGN 51) Reason for no Exercise Tolerance Test Common name: Reason for no ETT, Reason for no exercise ECG Definition: An explanation of why an exercise tolerance test was not performed where it might be expected to be performed, e.g. when clinical guidelines recommend echo should be performed 00 No reason No reason why ETT not performed 01 Contraindicated Generally acknowledged clinical contraindication to performing ETT exists, e.g. physically incapable of performing the test, may have aortic stenosis or cardiomyopathy 02 Not indicated No clinical indication for ETT e.g. diagnosis of CHD is unlikely or the results of stress testing would not affect management 03 Clinical decision Clinical judgement of inappropriateness of ETT investigation in an individual patient due to their specific set of circumstances 04 Not available ETT investigation not available 05 Not applicable 06 Patient declined Patient chose not to have ETT Related data items: Exercise Tolerance Test Acute Coronary Syndromes Dataset 34

35 Further information: Exercise tolerance testing (ETT) is used principally to identify patients with reversible myocardial ischaemia who might benefit from revascularisation. (Ref. SIGN 41) Echocardiography Common name: Echo, Cardiac ultrasound Definition: A record of whether or not echocardiographic investigation has been performed. 00 No Not performed 01 Yes 02 Planned Includes requested and referred for 99 Unknown Sub data item: Type of echocardiogram: 1 Transthoracic 2 Transoesophageal 3 Mitral 4 Atrial Related data items: Echocardiogram Results {CHD} Reason for no Echocardiogram Further information: The Echocardiography must be performed during this admission. Echocardiography is established as the standard means of assessing cardiac structure and function in clinical practice. It permits measurement of left ventricular size, shape, wall thickness, contraction, and relaxation. In addition, valve structure and function can be assessed and thrombus detected. Right ventricular measurements can also be made and pericardial effusion excluded. (Ref. SIGN 35) It is used to assess patient s post-mi, in those with heart failure, valvular heart disease or congenital heart disease. For various clinical conditions, specific clinical guidelines recommended echo investigation. Whether or not an echo was performed in line with such guidelines may be needed to assess the quality of clinical care. LV Function as Result of Echocardiogram Common name: Echo Results {CHD} Definition: A high level report on the findings of an echocardiography investigation, with reference to abnormalities which may be related to ischaemic heart disease and/or valvular disease. Format: 3 characters Acute Coronary Syndromes Dataset 35

36 Code Value Sub cod e 00 Normal 01 Abnormal 02 Inconclusive 99 Unknown Sub value Explanatory Notes Abnormalities detected on echo, but nature of abnormality not specified A LV impairment Echo suggestive of left ventricular impairment B LV hypertrophy Echo suggestive of left ventricular hypertrophy C Significant valve Echo suggestive of D E disease Non-significant valve disease Other abnormality significant valve disease Echo suggestive of nonsignificant valve disease Related data items: Echocardiogram (Investigation) Recording guidance: Multiple abnormalities may be recorded. Reason for No Echocardiography Common name: Reason for no Echo Definition: An explanation of why no echocardiogram was performed where it might be expected to be performed, e.g. when clinical guidelines recommend echo should be performed. 00 No reason No reason why Echo not performed 01 Contraindicated Generally acknowledged clinical contraindication to performing Echo exists, e.g. physically incapable of performing the test 02 Not indicated No clinical indication for Echo 03 Clinical decision Clinical judgement of inappropriateness of Echo investigation in an individual patient due to their specific set of circumstances 04 Not available Echo investigation not available 05 Not applicable 06 Patient declined Patient chose not to have Echo 99 Unknown Related data items: Echocardiography (Investigation) Referral for Coronary Angiography Acute Coronary Syndromes Dataset 36

37 Definition: A record of referral for coronary angiography in another hospital. 00 No Not performed 01 Yes 02 Planned Includes requested and referred for Date of Referral for Coronary Angiogram Definition: A record of the date a patient was referred for coronary angiogram Format: 10 characters (CCYY-MM-DD) N/A Sub data item: Verification Level Code Value Level 0 Actual Level 1 Estimated Level 2 Not known Recording guidance: Valid date >1/1/2000 and <= today. Coronary Angiography During This Admission {ACS} Definition: A record of whether or not coronary angiography investigation has been performed for delineation of coronary arterial blood-flow during this admission 00 Not performed 01 Protocol driven investigation performed in this hospital 02 Symptom driven investigation performed in this hospital 03 Protocol driven investigation performed at another hospital/centre 04 Symptom driven investigation performed at another hospital/centre 05 Not indicated Clinician considers angiography necessary for management in the absence of continuing clinical symptoms. Angiography performed for continuing symptoms. Clinician considers angiography necessary for management in the absence of continuing clinical symptoms. Angiography performed for continuing symptoms. Acute Coronary Syndromes Dataset 37

1 a) Please confirm or deny whether your Trust has admitted patients for acute myocardial infarction in 2008/09, 2009/10 or 2010/11

1 a) Please confirm or deny whether your Trust has admitted patients for acute myocardial infarction in 2008/09, 2009/10 or 2010/11 May 2011 1 a) Please confirm or deny whether your Trust has admitted patients for acute myocardial infarction in 2008/09, 2009/10 or 2010/11 Yes b) If confirmed please provide details on the number of

More information

4. Which survey program does your facility use to get your program designated by the state?

4. Which survey program does your facility use to get your program designated by the state? STEMI SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and STEMI

More information

Unstable angina and NSTEMI

Unstable angina and NSTEMI Issue date: March 2010 Unstable angina and NSTEMI The early management of unstable angina and non-st-segment-elevation myocardial infarction This guideline updates and replaces recommendations for the

More information

NHS QIS National Measurement of Audit Acute Coronary Syndrome

NHS QIS National Measurement of Audit Acute Coronary Syndrome NHS QIS National Measurement of Audit Acute Coronary Syndrome Things have changed based on the experience and feedback from the first cycle of measurement and, for the better we think! The Acute Coronary

More information

(For items 1-12, each question specifies mark one or mark all that apply.)

(For items 1-12, each question specifies mark one or mark all that apply.) Form 121 - Report of Cardiovascular Outcome Ver. 9.2 COMMENTS -Affix label here- Member ID: - - To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: - Central Case No.:

More information

APPENDIX F: CASE REPORT FORM

APPENDIX F: CASE REPORT FORM APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more

More information

Date of Meeting: Ratified Date: 03/06/2009

Date of Meeting: Ratified Date: 03/06/2009 Document Type: PROTOCOL Title: Management And Transfer Of Patients With Acute Scope: Cardiac Network-wide Author/Originator and Title: Dr Ranjit More & members of the Cardiac Network Clinical Advisory

More information

What is a myocardial infarction and how do we treat it? Paul Das Consultant Cardiologist North Wales Cardiac Centre Glan Clwyd Hospital

What is a myocardial infarction and how do we treat it? Paul Das Consultant Cardiologist North Wales Cardiac Centre Glan Clwyd Hospital What is a myocardial infarction and how do we treat it? Paul Das Consultant Cardiologist North Wales Cardiac Centre Glan Clwyd Hospital What is a myocardial infarction? THEY AINT WHAT THEY USED TO BE Case

More information

Repeat ischaemic heart disease audit of primary care patients ( ): Comparisons by age, sex and ethnic group

Repeat ischaemic heart disease audit of primary care patients ( ): Comparisons by age, sex and ethnic group Repeat ischaemic heart disease audit of primary care patients (2002-2003): Comparisons by age, sex and ethnic group Baseline-repeat ischaemic heart disease audit of primary care patients: a comparison

More information

Management of Acute Myocardial Infarction

Management of Acute Myocardial Infarction Management of Acute Myocardial Infarction Prof. Hossam Kandil Professor of Cardiology Cairo University ST Elevation Acute Myocardial Infarction Aims Of Management Emergency care (Pre-hospital) Early care

More information

Quality Payment Program: Cardiology Specialty Measure Set

Quality Payment Program: Cardiology Specialty Measure Set Quality Payment Program: Cardiology Specialty Set Title Number CMS Reporting Method(s) Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for

More information

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist physician Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Outcome objectives of the discussion: At the end of the

More information

Medicine Dr. Omed Lecture 2 Stable and Unstable Angina

Medicine Dr. Omed Lecture 2 Stable and Unstable Angina Medicine Dr. Omed Lecture 2 Stable and Unstable Angina Risk stratification in stable angina. High Risk; *post infarct angina, *poor effort tolerance, *ischemia at low workload, *left main or three vessel

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Myocardial infarction: secondary prevention in primary and secondary care for patients following a myocardial infarction 1.1

More information

Chronic Benefit Application Form Cardiovascular Disease and Diabetes

Chronic Benefit Application Form Cardiovascular Disease and Diabetes Chronic Benefit Application Form Cardiovascular Disease and Diabetes 19 West Street, Houghton, South Africa, 2198 Postnet Suite 411, Private Bag X1, Melrose Arch, 2076 Tel: +27 (11) 715 3000 Fax: +27 (11)

More information

DISCUSSION QUESTION - 1

DISCUSSION QUESTION - 1 CASE PRESENTATION 87 year old male No past history of diabetes, HTN, dyslipidemia or smoking Very active Medications: omeprazole for heart burn Admitted because of increasing retrosternal chest pressure

More information

Diagnosis and Management of Acute Myocardial Infarction

Diagnosis and Management of Acute Myocardial Infarction Diagnosis and Management of Acute Myocardial Infarction Acute Myocardial Infarction (AMI) occurs as a result of prolonged myocardial ischemia Atherosclerosis leads to endothelial rupture or erosion that

More information

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply. WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:

More information

Acute coronary syndromes

Acute coronary syndromes Acute coronary syndromes 1 Acute coronary syndromes Acute coronary syndromes results primarily from diminished myocardial blood flow secondary to an occlusive or partially occlusive coronary artery thrombus.

More information

Practitioner Education Course

Practitioner Education Course 2015 Practitioner Education Course ST Elevation Myocardial Infarction 2 Pathology Concept of vulnerable plaque Mild Atheroma Diagnosis IVUS OCT 3 Diagnosis This is based on : Clinical History ECG Changes.

More information

Richard Grocott Mason

Richard Grocott Mason Richard Grocott Mason What to do with a 50 year old man with chest pain? Does the pain sound cardiac? Is this a possible acute coronary syndrome? Does patient have a previous cardiac history? Natural history

More information

Quality Payment Program: Cardiology Specialty Measure Set

Quality Payment Program: Cardiology Specialty Measure Set Measure Title * Reportable via PINNACLE α Reportable via Diabetes Collaborative CQMC v1.0 Measure High Priority Measure Cross Cutting Measure Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor

More information

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for, Atrial Fibrillation, Hypertension and.

More information

GWTG-CAD: Mission: Lifeline Focus July 2017 PMT FORM SELECTION. Pre-Hospital/Arrival

GWTG-CAD: Mission: Lifeline Focus July 2017 PMT FORM SELECTION. Pre-Hospital/Arrival GWTG-CAD: Mission: Lifeline Focus July 2017 PMT FORM SELECTION Page 1 Legend: BOLD = Required ^ = MLL Data Element Admin (Tab) ^Patient ID: Physician/Provider NPI: DOB: / / ^Arrival Date/Time: Race: Hispanic

More information

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in

More information

Policy Register No: Status: Public. Contributes to Care Quality Commission Outcome 4

Policy Register No: Status: Public. Contributes to Care Quality Commission Outcome 4 Operational Policy for Transfer of ST Elevation MI (STEMI) patients to Essex Cardiothoracic Centre (ECTC) for Primary Percutaneous Coronary Intervention Policy Register No: 09122 Status: Public Developed

More information

SCOTTISH STROKE CARE AUDIT DATA COLLECTION QUICK NOTES

SCOTTISH STROKE CARE AUDIT DATA COLLECTION QUICK NOTES SCOTTISH STROKE CARE AUDIT DATA COLLECTION QUICK TES Version 4.0 Updated December 2013 (For review November 2017) 1a. Patients to be included in the audit (Inpatient form) All patients with stroke or TIA

More information

ATTENDING PHYSICIAN'S STATEMENT HEART ATTACK / CARDIOMYOPATHY / PERICARDIAL DISEASE / CARDIAC ARRYTHMIA

ATTENDING PHYSICIAN'S STATEMENT HEART ATTACK / CARDIOMYOPATHY / PERICARDIAL DISEASE / CARDIAC ARRYTHMIA ATTENDING PHYSICIAN'S STATEMENT HEART ATTACK / CARDIOMYOPATHY / PERICARDIAL DISEASE / CARDIAC ARRYTHMIA A) Patient s Particulars Name of Patient Gender NRIC/FIN or Passport No. Date of Birth (ddmmyyyy)

More information

New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.)

New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.) A. ADMINISTRATIVE New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.) 1. Facility Code: 2. Facility Name: 3. Procedure Type (Choose only

More information

Evaluation of a diagnostic pathway in heart failure in primary care, using electrocardiography and brain natriuretic peptide guided echocardiography

Evaluation of a diagnostic pathway in heart failure in primary care, using electrocardiography and brain natriuretic peptide guided echocardiography Evaluation of a diagnostic pathway in heart failure in primary care, using electrocardiography and brain natriuretic peptide guided echocardiography Rebecka Karlsson Pardeep Jhund 1 Material and methods

More information

Improving the Outcomes of

Improving the Outcomes of Improving the Outcomes of STEMI Shelley Valaire, ACP; and Robert Welsh, MD, FRCPC Presented at the University of Alberta s 6th Annual Cardiology Update for General Practitioners and Internists, Edmonton,

More information

Belinda Green, Cardiologist, SDHB, 2016

Belinda Green, Cardiologist, SDHB, 2016 Acute Coronary syndromes All STEMI ALL Non STEMI Unstable angina Belinda Green, Cardiologist, SDHB, 2016 Thrombus in proximal LAD Underlying pathophysiology Be very afraid for your patient Wellens

More information

The organisation of troponin testing services in acute coronary syndromes

The organisation of troponin testing services in acute coronary syndromes Health Technology Assessment Advice 4 ~ December 2003 The organisation of troponin testing services in acute coronary syndromes Summary of recommendations NHS Quality Improvement Scotland recommends that

More information

ST-elevation myocardial infarctions (STEMIs)

ST-elevation myocardial infarctions (STEMIs) Guidelines for Treating STEMI: Case-Based Questions As many as 25% of eligible patients presenting with STEMI do not receive any form of reperfusion therapy. The ACC/AHA guidelines highlight steps to improve

More information

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003 Authorized By: Medical Management Guideline Committee Approval Date: 12/13/01 Revision Date: 12/11/03 Beta-Blockers Nitrates Calcium Channel Blockers MEDICATIONS Indicated in post-mi, unstable angina,

More information

NCDR CathPCI Registry v4.4 Diagnostic Catheterization and Percutaneous Coronary Intervention Registry

NCDR CathPCI Registry v4.4 Diagnostic Catheterization and Percutaneous Coronary Intervention Registry A. DEMOGRAPHICS Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : - - - SSN N/A 2031 Patient ID 2040 : (auto) Other ID 2045 : Birth Date 2050 : *** @ Sex 2060 : *** @ O Male O Female Race:

More information

Otamixaban for non-st-segment elevation acute coronary syndrome

Otamixaban for non-st-segment elevation acute coronary syndrome Otamixaban for non-st-segment elevation acute coronary syndrome September 2011 This technology summary is based on information available at the time of research and a limited literature search. It is not

More information

When the learner has completed this module, she/he will be able to:

When the learner has completed this module, she/he will be able to: Thrombolytics and Myocardial Infarction WWW.RN.ORG Reviewed September 2017, Expires September 2019 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2017

More information

Consultation Group: Cardiology Consultants Clinical lead for cardiology: Dr Andrew Hannah. Review Date: Uncontrolled when printed.

Consultation Group: Cardiology Consultants Clinical lead for cardiology: Dr Andrew Hannah. Review Date: Uncontrolled when printed. NHS Grampian Staff Guidelines For The In-Hospital Management Of Unstable Angina And Non-ST-Segment- Elevation Myocardial Infarction Patients (17 Years And Older) Co-ordinators: Cardiology Specialist Clinical

More information

Practice-Level Executive Summary Report

Practice-Level Executive Summary Report PINNACLE Registry Metrics 0003, Test Practice_NextGen [Rolling: 1st April 2015 to 31st March 2016 ] Generated on 5/11/2016 11:37:35 AM American College of Cardiology Foundation National Cardiovascular

More information

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,

More information

Acute Myocardial Infarction

Acute Myocardial Infarction Acute Myocardial Infarction Hafeza Shaikh, DO, FACC, RPVI Lourdes Cardiology Services Asst.Program Director, Cardiology Fellowship Associate Professor, ROWAN-SOM Acute Myocardial Infarction Definition:

More information

OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION

OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION FEROZ MEMON*, LIAQUAT CHEEMA**, NAND LAL RATHI***, RAJ KUMAR***, NAZIR AHMED MEMON**** OBJECTIVE: To compare morbidity,

More information

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI) Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for Artery, Atrial Fibrillation, Hypertension

More information

Sheffield guidelines for the use of antiplatelets in the prevention and treatment of cardiovascular disease (October 2017)

Sheffield guidelines for the use of antiplatelets in the prevention and treatment of cardiovascular disease (October 2017) Sheffield guidelines f the use of antiplatelets in the prevention and treatment of cardiovascular disease (October 2017) Approved by Sheffield Area Prescribing Committee and Sheffield Teaching Hospitals

More information

Myocardial Infarction In Dr.Yahya Kiwan

Myocardial Infarction In Dr.Yahya Kiwan Myocardial Infarction In 2007 Dr.Yahya Kiwan New Definition Of Acute Myocardial Infarction The term of myocardial infarction should be used when there is evidence of myocardial necrosis in a clinical setting

More information

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM Version 4.4 Institutional Outcomes Report 2014Q3 National Outcomes Report 999997 Aggregation Date: Jan 12, 2015 11:59:59 PM Publish Date: Jan 29, 2015 If User desires to publish or otherwise distribute

More information

21/06/2018. MEASURING PERFORMANCE (AUDIT AND QUALITY IMPROVEMENT) Towards Reducing Inequity. What should we be measuring?

21/06/2018. MEASURING PERFORMANCE (AUDIT AND QUALITY IMPROVEMENT) Towards Reducing Inequity. What should we be measuring? MEASURING PERFORMANCE (AUDIT AND QUALITY IMPROVEMENT) Towards Reducing Inequity Dr Raewyn Fisher Cardiologist Director of Waikato Integrated Heart Failure Service What should we be measuring? At risk,

More information

Is it safe to discharge patients 24 hours after uncomplicated successful primary percutaneous coronary intervention

Is it safe to discharge patients 24 hours after uncomplicated successful primary percutaneous coronary intervention Is it safe to discharge patients 24 hours after uncomplicated successful primary percutaneous coronary intervention DA Jones, J Howard, S Gallagher, KS Rathod, A Jain, S Mohiddin, C Knight, A Mathur, EJ

More information

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

Acute Myocardial Infarction. Willis E. Godin D.O., FACC Acute Myocardial Infarction Willis E. Godin D.O., FACC Acute Myocardial Infarction Definition: Decreased delivery of oxygen and nutrients to the myocardium Myocardial tissue necrosis causing irreparable

More information

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case History A 50-year-old man with type 1 diabetes mellitus and hypertension presents after experiencing 1 hour of midsternal chest pain that began after

More information

STEMI, Non-STEMI, Chest Pain?

STEMI, Non-STEMI, Chest Pain? Minnesota Chest Pain / Acute Coronary Syndrome Tool-Kit Patient with Chest Pain Or Potential Acute Coronary Syndrome STEMI, n-stemi, Chest Pain? Follow MN STEMI Guideline Follow MN n-stemi Guideline Follow

More information

2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction

2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction Ramzi Khalil MD FACC Assistant Professor Allegheny Gen.Hospital AHN Speakers

More information

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18 UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18 INTRODUCTION The clinical entities that comprise acute coronary syndromes (ACS)-ST-segment

More information

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set Unless indicated, the PINNACLE Registry measures are endorsed by the American College of Cardiology Foundation and the American Heart Association and may be used for purposes of health care insurance payer

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: Assessment and immediate management of suspected acute coronary syndrome bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They

More information

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA Dr Lincoff is an interventional cardiologist and the Vice Chairman for Research

More information

Acute Coronary Syndrome (ACS) Initial Evaluation and Management

Acute Coronary Syndrome (ACS) Initial Evaluation and Management Acute Coronary Syndrome (ACS) Initial Evaluation and Management Symptoms of Possible ACS Chest discomfort with or without radiation to the arm(s), jaw, or epigastrium Short of breath Weakness Diaphoresis

More information

Do Not Cite. Draft for Work Group Review.

Do Not Cite. Draft for Work Group Review. Defect Free Acute Inpatient Ischemic Stroke Measure Bundle Measure Description Percentage of patients aged 18 years and older with a diagnosis of ischemic stroke OR transient ischemic attack who were admitted

More information

How to give thrombolysis in acute myocardial infarction

How to give thrombolysis in acute myocardial infarction Page 1 of 6 How to give thrombolysis in acute myocardial infarction Original article: Michael Tam In the major urban hospitals, there will be little place for thrombolysis in acute STEMI (STelevation myocardial

More information

HEART CONDITIONS IN SPORT

HEART CONDITIONS IN SPORT HEART CONDITIONS IN SPORT Dr. Anita Green CHD Risk Factors Smoking Hyperlipidaemia Hypertension Obesity Physical Inactivity Diabetes Risks are cumulative (multiplicative) Lifestyles predispose to RF One

More information

Chest Pain. Dr Robert Huggett Consultant Cardiologist

Chest Pain. Dr Robert Huggett Consultant Cardiologist Chest Pain Dr Robert Huggett Consultant Cardiologist Outline Diagnosis of cardiac chest pain 2016 NICE update on stable chest pain Assessment of unstable chest pain/acs and MI definition Scope of the

More information

FastTest. You ve read the book now test yourself

FastTest. You ve read the book now test yourself FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. The answers will refer you back to

More information

Clinical guideline Published: 23 July 2011 nice.org.uk/guidance/cg126

Clinical guideline Published: 23 July 2011 nice.org.uk/guidance/cg126 Stable angina: management Clinical guideline Published: 23 July 2011 nice.org.uk/guidance/cg126 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Diagnostics guidance Published: 1 October 2014 nice.org.uk/guidance/dg15

Diagnostics guidance Published: 1 October 2014 nice.org.uk/guidance/dg15 Myocardial infarction (acute): Early rule out using high-sensitivity troponin tests (Elecsys Troponin T high-sensitive, e, ARCHITECT STAT T High Sensitive Troponin-I and AccuTnI+3 assays) Diagnostics guidance

More information

bivalirudin 250mg powder for concentrate for solution for injection or infusion (Angiox) SMC No. (638/10) The Medicines Company

bivalirudin 250mg powder for concentrate for solution for injection or infusion (Angiox) SMC No. (638/10) The Medicines Company bivalirudin 250mg powder for concentrate for solution for injection or infusion (Angiox) SMC No. (638/10) The Medicines Company 06 August 2010 The Scottish Medicines Consortium (SMC) has completed its

More information

ATTENDING PHYSICIAN'S STATEMENT CORONARY ARTERY BY-PASS SURGERY or OTHER SERIOUS CORONARY ARTERY DISEASE

ATTENDING PHYSICIAN'S STATEMENT CORONARY ARTERY BY-PASS SURGERY or OTHER SERIOUS CORONARY ARTERY DISEASE ATTENDING PHYSICIAN'S STATEMENT CORONARY ARTERY BY-PASS SURGERY or OTHER SERIOUS CORONARY ARTERY DISEASE A) Patient s Particulars Name of Patient Gender NRIC/FIN or Passport No. Date of Birth (ddmmyyyy)

More information

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group Primary and Secondary Prevention of Cardiovascular Disease Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group AHA Diet and Lifestyle Recommendations Balance calorie intake and physical activity to

More information

The PAIN Pathway for the Management of Acute Coronary Syndrome

The PAIN Pathway for the Management of Acute Coronary Syndrome 2 The PAIN Pathway for the Management of Acute Coronary Syndrome Eyal Herzog, Emad Aziz, and Mun K. Hong Acute coronary syndrome (ACS) subsumes a spectrum of clinical entities, ranging from unstable angina

More information

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor 76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class

More information

Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504

Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Transcatheter valve-in-valve e implantation for aortic bioprosthetic valve dysfunction Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Your responsibility This

More information

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1. Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical

More information

This information explains the advice about the care and treatment of people with stable angina that is set out in NICE clinical guideline 126.

This information explains the advice about the care and treatment of people with stable angina that is set out in NICE clinical guideline 126. Information for the public Published: 1 July 2011 nice.org.uk About this information NICE clinical guidelines advise the NHS on caring for people with specific conditions or diseases and the treatments

More information

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER: ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM General Instructions: The Heart Failure Hospital Record Abstraction Form is completed for all heart failure-eligible cohort hospitalizations. Refer to

More information

Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial

Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial compared with clopidogrel in patients with acute coronary syndromes the PLATO trial August 30, 2009 at 08.00 CET PLATO background In NSTE-ACS and STEMI, current guidelines recommend 12 months aspirin and

More information

Cardiology when to refer

Cardiology when to refer when to refer Referral criteria are never absolute but some essential guidelines can be found here. PATRICK COMMERFORD, MB ChB, FCP (SA) Professor of Cardiology, Department of Medicine, University of Cape

More information

Commissioning for value focus pack

Commissioning for value focus pack Commissioning for value focus pack Clinical commissioning group: NHS MILTON KEYNES CCG Focus area: Cardiovascular disease (CVD) pathway Version 2 June 2014 Contents 1. Background and context About the

More information

Decrease cost of inpatient stay Decrease bed diversions Improve bed utilization (Interqual Criteria) Patient Satisfaction Reduce patient costs

Decrease cost of inpatient stay Decrease bed diversions Improve bed utilization (Interqual Criteria) Patient Satisfaction Reduce patient costs Decrease cost of inpatient stay Decrease bed diversions Improve bed utilization (Interqual Criteria) Patient Satisfaction Reduce patient costs (family hotel, drive back to the VA for next day pick up)

More information

South Tyneside Exercise Referral and Weight Management Programme

South Tyneside Exercise Referral and Weight Management Programme South Tyneside Exercise Referral and Weight Management Programme Referral Guidance Document 2011/2012 1 2 South Tyneside Exercise Referral and Community Weight Management Programme Introduction An Exercise

More information

2012 Core Measures. Acute Myocardial Infarction (AMI)

2012 Core Measures. Acute Myocardial Infarction (AMI) 2012 Core Measures Acute Myocardial Infarction (AMI) Aspirin at Arrival Aspirin Prescribed at Discharge Angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) for left ventricular

More information

Cardiology The interface between Primary and Secondary Care

Cardiology The interface between Primary and Secondary Care Cardiology The interface between Primary and Secondary Care Dr A Daniels GP, Cardiff South East Wales Cardiac Network The view from secondary care Referral to treatment times targets Clinics are full of

More information

Diagnostics consultation document

Diagnostics consultation document National Institute for Health and Care Excellence Diagnostics consultation document Myocardial infarction (acute): Early rule out using high-sensitivity troponin tests (Elecsys Troponin T high-sensitive,

More information

Chest pain management. Ruvin Gabriel and Niels van Pelt August 2011

Chest pain management. Ruvin Gabriel and Niels van Pelt August 2011 Chest pain management Ruvin Gabriel and Niels van Pelt August 2011 Introduction Initial assessment Case 1 Case 2 and 3 Comparison of various diagnostic techniques Summary 1-2 % of GP consultations are

More information

6/1/18 LEARNING OBJECTIVES PATIENT POPULATION PRESENTATIONS

6/1/18 LEARNING OBJECTIVES PATIENT POPULATION PRESENTATIONS PREVENTING HOSPITAL READMISSIONS IN CARDIOVASCULAR PATIENTS Christina Cortez Perry, MSN, FNP-C, CCCC Cardiology Coordinator- Corpus Christi Medical Center 1 2 LEARNING OBJECTIVES Identify the target patient

More information

Protecting the heart and kidney: implications from the SHARP trial

Protecting the heart and kidney: implications from the SHARP trial Cardiology Update, Davos, 2013: Satellite Symposium Protecting the heart and kidney: implications from the SHARP trial Colin Baigent Professor of Epidemiology CTSU, University of Oxford S1 First CTT cycle:

More information

Role of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University

Role of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University Role of Clopidogrel in Acute Coronary Syndromes Hossam Kandil,, MD Professor of Cardiology Cairo University ACS Treatment Strategies Reperfusion/Revascularization Therapy Thrombolysis PCI (with/ without

More information

Cardiac Rehabilitation after Primary Coronary Intervention CONTRA

Cardiac Rehabilitation after Primary Coronary Intervention CONTRA DEBATE SESSION Is there a role for cardiac rehabilitation in the modern era of Percutaneous coronary intervention and coronary artery bypass grafting? Cardiac Rehabilitation after Primary Coronary Intervention

More information

New indicators to be added to the NICE menu for the QOF and amendments to existing indicators

New indicators to be added to the NICE menu for the QOF and amendments to existing indicators New indicators to be added to the for the QOF and amendments to existing indicators 1 st September 2015 Version 1.1 This document was originally published on 3 rd August 2015, it has since been updated.

More information

The following principles relating to the Quality and Outcomes Framework (QOF) were agreed by the negotiators.

The following principles relating to the Quality and Outcomes Framework (QOF) were agreed by the negotiators. Quality and outcomes framework Guidance 2006 Section 1: Principles The following principles relating to the Quality and Outcomes Framework (QOF) were agreed by the negotiators. 1 Indicators should, where

More information

Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease. Produced on behalf of NHS Wales and Welsh Government

Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease. Produced on behalf of NHS Wales and Welsh Government Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease Produced on behalf of NHS Wales and Welsh Government April 2018 Table of Contents Introduction... 3 Variation in health services...

More information

New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0.

New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0. New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0. Measure Steward Measure Name Measure Description Rationale for Adding

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Chung S-C, Gedeborg R, Nicholas O, et al. Acute

More information

2. Quality and Outcomes Framework: new NICE recommendations

2. Quality and Outcomes Framework: new NICE recommendations Proposed Changes to the GMS Contract 2013/14 1. GP pay and expenses uplift It is proposed GP pay and expenses is uplifted by 1.5%. This increased investment will allow for an average pay increase of up

More information

DICOM Correction Item

DICOM Correction Item Correction Number CP-759 DICOM Correction Item Log Summary: Type of Modification Modification Rationale for Correction Name of Standard PS 3.16 The templates for Cardiovascular Patient History, originally

More information

Attending Physician Statement- Heart Attack

Attending Physician Statement- Heart Attack Instruction to doctor: This patient is insured with us against the happening of certain contingent events associated with his health. A claim has been submitted in connection with Heart attack / Cardiomyopathy

More information

Perioperative Cardiovascular Evaluation and Care for Noncardiac. Dr Mahmoud Ebrahimi Interventional cardiologist 91/9/30

Perioperative Cardiovascular Evaluation and Care for Noncardiac. Dr Mahmoud Ebrahimi Interventional cardiologist 91/9/30 Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery Dr Mahmoud Ebrahimi Interventional cardiologist 91/9/30 Active Cardiac Conditions for Which the Patient Should Undergo Evaluation

More information

Quality and Outcomes Framework guidance for GMS contract 2009/10. Delivering investment in general practice

Quality and Outcomes Framework guidance for GMS contract 2009/10. Delivering investment in general practice Quality and Outcomes Framework guidance for GMS contract 2009/10 Delivering investment in general practice March 2009 Contents Section 1. Principles 3 Section 2. Clinical Indicators 7 Secondary prevention

More information

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Canadian Best Practice Recommendations for Stroke Care (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Reorganization of Recommendations 2008 2006 RECOMMENDATIONS: 2008 RECOMMENDATIONS:

More information

Acute myocardial infarction. Cardiovascular disorders. main/0202_new 02/03/06. Search date August 2004 Nicholas Danchin and Eric Durand

Acute myocardial infarction. Cardiovascular disorders. main/0202_new 02/03/06. Search date August 2004 Nicholas Danchin and Eric Durand main/0202_new 02/03/06 Acute myocardial infarction Search date August 2004 Nicholas Danchin and Eric Durand QUESTIONS Which treatments improve outcomes in acute myocardial infarction?...4 Which treatments

More information